The global losartan market is poised to grow on the basis of growing incidence of hypertension and increase in prefrail geriatric population. Losartan is used for lessening the risk of stroke in those who have higher blood pressure and left ventricular hypertrophy.
It is advisable to consult the doctor if an unexplained tenderness, muscle pain, or weakness is experienced on intake of losartan.
The companies operating in the losartan market are working toward incorporating an enhanced therapeutic efficacy of combining chemo-immunotherapy and losartan for triple negative breast cancer.
They are also exploring incorporation of losartan for reducing the ensuing chronic kidney disease as well as mortality post-acute kidney injury. Moreover, the regions such as Latin America and Middle East & Africa are being educated by them regarding the usage of losartan.
Losartan is either used alone or with the other medicines for treating hypertension (high blood pressure). Higher blood pressure increases workload of arteries and heart.
If this continues for long, arteries and heart may not function in the proper manner. This can, in turn, severely damage blood vessels of kidneys, heart, and brain, thereby resulting in heart failure, stroke, or kidney failure.
Losartan is an angiotensin II receptor blocker (ARB). It blocks a substance that causes blood vessels to tighten. As an outcome, losartan relaxes blood vessels. Lower blood pressure would, in turn, increase supply of oxygen and blood to heart.
Losartan is also prescribed for patients living with kidney problems and those who have a history of hypertension and type 2 diabetes. The medicine is not allowed to be made available without doctor’s prescription.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
UTHealth Houston states that a commonly used blood pressure medication in the form of losartan is bound to improve the measures of frailty in the prefrail older adults.
Prefrail adults are the ones who are vulnerable to several adverse health outcomes that include functional decline, early mortality, falls, and disability.
Study conducted by researchers at McGovern Medical School at UTHealth Houston has stated that frailty scores in the patients mentioned above have lowered on having losartan along with improvement in physical function.
Delving deeper has resulted in another fact getting surfaced, i.e. losartan group shows improvements in molecular levels of these patients as well. Stress markers and metabolism are thus reported to witness positive changes.
Increase in the number of prefrail adults is thus accelerating the losartan market growth.
Losartan, in case of hypertension with left ventricular hypertrophy, inhibits angiotensin II-induced cardiac remodeling, thereby minimizing the risk of stroke in patients. In other words, losartan broadens and relaxes the blood vessels. It lowers the blood pressure and makes it simpler for heart to pump blood around the body.
As per the report published in AHA Journals, blood pressure could be controlled in 50% of the patients after 12 weeks of active treatment with losartan.
As per the WHO, 1.3 billion individuals are living with hypertension worldwide and the number is expected to increase twofold during the forecast period.
Increase in incidence of hypertension worldwide and the need to combat it are thus driving the losartan market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest losartan market statistics, North America led the losartan landscape in 2023 and the status quo is expected to remain unchanged during the forecast period. This is attributed to the rising awareness regarding the importance of losartan amongst the population in the U.S.
Asia Pacific’s significant losartan market share is ascribed to the rise in preference for losartan as a means to cure hypertension amongst Singapore- and Malaysia-based population. Several awareness campaigns are being conducted in countries such as India and China to increase the consumer base.
The key players in the losartan market are investing in devising advanced versions of losartan tablets in order to strengthen their position.
Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Limited, and Lupin Limited are some of the key players covered in the losartan market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 1.5 Bn |
| Market Forecast (Value) in 2034 | US$ 2.3 Bn |
| Growth Rate (CAGR) | 4.0% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 1.5 Bn in 2023
It is projected to grow at a CAGR of 4.0% from 2024 to 2034
Increase in prefrail geriatric population and rise in incidence of hypertension
Contract manufacturing segment accounted for the largest share in 2023
North America was the dominant region in 2023
Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Limited, and Lupin Limited
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Losartan Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Losartan Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Losartan Market Analysis and Forecast, by Dosage Form
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Dosage Form, 2020-2034
6.3.1. Tablet
6.3.2. Powder
6.3.3. Suspension
6.4. Market Attractiveness Analysis, by Dosage Form
7. Global Losartan Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Hypertension
7.3.2. Stroke
7.3.3. Diabetic Nephropathy
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Losartan Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Contract Manufacturing
8.3.2. In-house Manufacturing
8.3.3. Others
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Losartan Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Losartan Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Dosage Form, 2020-2034
10.3.1. Tablet
10.3.2. Powder
10.3.3. Suspension
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Hypertension
10.4.2. Stroke
10.4.3. Diabetic Nephropathy
10.4.4. Others
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Contract Manufacturing
10.5.2. In-house Manufacturing
10.5.3. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Dosage Form
10.7.2. By Application
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Losartan Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Dosage Form, 2020-2034
11.3.1. Tablet
11.3.2. Powder
11.3.3. Suspension
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Hypertension
11.4.2. Stroke
11.4.3. Diabetic Nephropathy
11.4.4. Others
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Contract Manufacturing
11.5.2. In-house Manufacturing
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Dosage Form
11.7.2. By Application
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Losartan Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Dosage Form, 2020-2034
12.3.1. Tablet
12.3.2. Powder
12.3.3. Suspension
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Hypertension
12.4.2. Stroke
12.4.3. Diabetic Nephropathy
12.4.4. Others
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Contract Manufacturing
12.5.2. In-house Manufacturing
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Dosage Form
12.7.2. By Application
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Losartan Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Dosage Form, 2020-2034
13.3.1. Tablet
13.3.2. Powder
13.3.3. Suspension
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Hypertension
13.4.2. Stroke
13.4.3. Diabetic Nephropathy
13.4.4. Others
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Contract Manufacturing
13.5.2. In-house Manufacturing
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Dosage Form
13.7.2. By Application
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Losartan Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Dosage Form, 2020-2034
14.3.1. Tablet
14.3.2. Powder
14.3.3. Suspension
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Hypertension
14.4.2. Stroke
14.4.3. Diabetic Nephropathy
14.4.4. Others
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Contract Manufacturing
14.5.2. In-house Manufacturing
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Dosage Form
14.7.2. By Application
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Merck & Co., Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Pfizer Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Teva Pharmaceutical Industries Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Dr. Reddy’s Laboratories Ltd.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Sun Pharmaceutical Industries Limited
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Aurobindo Pharma Ltd
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Torrent Pharmaceuticals Limited
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Lupin Limited
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
List of Tables
Table 01: Global Losartan Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
Table 02: Global Losartan Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 03: Global Losartan Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 04: Global Losartan Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Losartan Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Losartan Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
Table 07: North America Losartan Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 08: North America Losartan Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 09: Europe Losartan Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Losartan Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
Table 11: Europe Losartan Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 12: Europe Losartan Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 13: Asia Pacific Losartan Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Losartan Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
Table 15: Asia Pacific Losartan Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific Losartan Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 17: Latin America Losartan Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Losartan Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
Table 19: Latin America Losartan Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 20: Latin America Losartan Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 21: Middle East & Africa Losartan Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Losartan Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
Table 23: Middle East & Africa Losartan Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa Losartan Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
List of Figures
Figure 01: Global Losartan Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Losartan Market Revenue (US$ Bn), by Dosage Form, 2023
Figure 03: Global Losartan Market Value Share, by Dosage Form, 2023
Figure 04: Global Losartan Market Revenue (US$ Bn), by Application, 2023
Figure 05: Global Losartan Market Value Share, by Application, 2023
Figure 06: Global Losartan Market Revenue (US$ Bn), by Distribution Channel, 2023
Figure 07: Global Losartan Market Value Share, by Distribution Channel, 2023
Figure 08: Global Losartan Market Value Share, by Region, 2023
Figure 09: Global Losartan Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Losartan Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 11: Global Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Losartan Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global Losartan Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Global Losartan Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 15: Global Losartan Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 16: Global Losartan Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Losartan Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Losartan Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Losartan Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Losartan Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 22: North America Losartan Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America Losartan Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 24: North America Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Losartan Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America Losartan Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 27: Europe Losartan Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Losartan Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Losartan Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Losartan Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 31: Europe Losartan Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe Losartan Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Europe Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Losartan Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe Losartan Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 36: Asia Pacific Losartan Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Losartan Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Losartan Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Losartan Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 40: Asia Pacific Losartan Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific Losartan Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 42: Asia Pacific Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Losartan Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific Losartan Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 45: Latin America Losartan Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Losartan Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Losartan Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Losartan Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 49: Latin America Losartan Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America Losartan Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 51: Latin America Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Losartan Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America Losartan Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 54: Middle East & Africa Losartan Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Losartan Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Losartan Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Losartan Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 58: Middle East & Africa Losartan Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa Losartan Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 60: Middle East & Africa Losartan Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Losartan Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa Losartan Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Losartan Market
